Pralurbactam

N/A

Report date: 2026/02/24 20:00:16
NME

Base Information

Drug NamePralurbactam
Drug Alias NameFL-058FL058
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsHospital-acquired pneumoniaPyelonephritisUrinary Tract Infections +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaPyelonephritisUrinary Tract Infections +[5] 
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A